List view / Grid view
29 September 2010 | By AstraZeneca
AstraZeneca announced the enrollment of the first patient in the phase III clinical development programme for fostamatinib...
29 September 2010 | By Citigate Dewe Rogerson
Creabilis SA, today announced the appointment of Eliot Forster as its new Chief Executive Officer...
27 September 2010 | By AstraZeneca
AstraZeneca announced that a study evaluating zibotentan for the treatment of men with metastatic CRPC did not show improvement in the primary endpoint of overall survival...
27 September 2010 | By Kapler Communications
Copley Scientific has introduced a new version of its widely used CITDAS...
24 September 2010 | By AstraZeneca
AstraZeneca announced that the CHMP issued a positive opinion on the marketing authorisation...
23 September 2010 | By Synexus
Synexus has appointed Dr Glynis Neagle as Chief Medical Officer...
23 September 2010 | By kdm communications limited
The Clinical Pharmacology Department has chosen Tecan’s Freedom EVO® platform to automate research into the pharmacology of anti-malarial and anti-influenza drugs...
23 September 2010 | By Citigate Dewe Rogerson
OBN, announced today that global specialty pharmaceutical company Shire has become the network’s first Corporate Patron...
20 September 2010 | By kdm communications limited
bioMérieux, was chosen by National Health Service Blood and Transplant (NHSBT) for bacterial screening of platelets in England and North Wales...
15 September 2010 | By Citigate Dewe Rogerson on behalf of Creabilis SA
Creabilis SA, today announced the appointment of George F. Horner III as its Chairman...
14 September 2010 | By kdm communications limited
Sigma® Life Science, signed a 3 year contract with RCUK Shared Services Centre to be a prefered supplier for synthetic oligonucleotides...
13 September 2010 | By Rexahn Pharmaceuticals
Rexahn Pharmaceuticals, Inc. announced the appointment of Peter Brandt and Richard Kivel to the company's board of directors...
10 September 2010 | By NG Online News
Fears of layoffs at pharmaceutical companies are once again dominating the news, but could there be a less painful way to save money?
7 September 2010 | By AD Communications
Brecon Pharmaceuticals has followed its strong 2009 performance with a record performance in 2010...
7 September 2010 | By Public Ltd
The Government’s Medicines & Healthcare Products Regulatory Agency, is currently spearheading a drive for continuous temperature monitoring right across the ‘cold chain’...
